{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:19:19Z","timestamp":1765819159165,"version":"3.48.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jvsvs.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JVS-Vascular Science"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.jvssci.2024.100277","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T18:17:12Z","timestamp":1734545832000},"page":"100277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Moving away from metal: Step toward the future with bioresorbable vascular scaffolds and novel antiproliferative agents"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0832-6358","authenticated-orcid":false,"given":"Blair E.","family":"Warren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kong-Teng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dheeraj K.","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda","family":"Witheford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Jaberi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Mafeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvssci.2024.100277_bib1","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jvssci.2024.100277_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amepre.2006.12.010","article-title":"Ethnic-specific prevalence of peripheral arterial disease in the United States","volume":"32","author":"Allison","year":"2007","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jvssci.2024.100277_bib3","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(23)00462-2","volume":"401","author":"Bradbury","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jvssci.2024.100277_bib4","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvssci.2024.100277_bib5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jvs.2024.05.049","article-title":"Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions","volume":"80","author":"Giles","year":"2024","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvssci.2024.100277_bib6","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1161\/CIRCRESAHA.121.318258","article-title":"Contemporary medical management of peripheral artery disease","volume":"128","author":"Bonaca","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jvssci.2024.100277_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jvs.2016.09.031","article-title":"Diagnosis, classification, and treatment of femoropopliteal artery in-stent restenosis","volume":"65","author":"Ho","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvssci.2024.100277_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ejvs.2023.07.038","article-title":"Poor below knee runoff impacts femoropopliteal stent failure and fluoropolymer antithrombotic effect in healthy swine model","volume":"66","author":"Nakamura","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvssci.2024.100277_bib9","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jvs.2017.09.040","article-title":"Long-term outcome of endovascular popliteal artery aneurysm repair","volume":"67","author":"Golchehr","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvssci.2024.100277_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.113.000937","article-title":"Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUPERB trial","volume":"8","author":"Garcia","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvssci.2024.100277_bib11","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.jvs.2018.06.072","article-title":"Multivessel tibial revascularization does not improve outcomes in patients with critical limb ischemia","volume":"68","author":"Lavingia","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvssci.2024.100277_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.23736\/S0392-9590.19.04049-5","article-title":"The use of drug-eluting stents in infrapopliteal arteries: an updated systematic review and meta-analysis of randomized trials","volume":"38","author":"Varcoe","year":"2019","journal-title":"Int Angiol"},{"key":"10.1016\/j.jvssci.2024.100277_bib13","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/CIRCRESAHA.121.318261","article-title":"Advances in revascularization for peripheral artery disease: revascularization in PAD","volume":"128","author":"Beckman","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jvssci.2024.100277_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.12793\/tcp.2023.31.e18","article-title":"A review of the current state in neointimal hyperplasia development following endovascular intervention and minor emphasis on new horizons in immunotherapy","volume":"31","author":"Dinc","year":"2023","journal-title":"Transl Clin Pharmacol"},{"key":"10.1016\/j.jvssci.2024.100277_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.98.3.224","article-title":"Neointimal tissue response at sites of coronary stenting in humans","volume":"98","author":"Komatsu","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jvssci.2024.100277_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0735-1097(97)00450-6","article-title":"In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia","volume":"31","author":"Kornowski","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvssci.2024.100277_bib17","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.jvs.2021.05.058","article-title":"Endovascular community response to mortality data in use of paclitaxel devices for peripheral vascular disease","volume":"74","author":"Warren","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvssci.2024.100277_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jacc.2005.09.047","article-title":"Sirolimus and paclitaxel on polymer-based drug-eluting stents: similar but different","volume":"47","author":"Wessely","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvssci.2024.100277_bib19","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J","article-title":"Paclitaxel-induced cell death: where the cell cycle and apoptosis come together","volume":"88","author":"Wang","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jvssci.2024.100277_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1568009033481967","article-title":"Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action","volume":"3","author":"Abal","year":"2003","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.jvssci.2024.100277_bib21","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.jvssci.2024.100277_bib22","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.299.16.1903","article-title":"Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial","volume":"299","author":"Stone","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jvssci.2024.100277_bib23","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvssci.2024.100277_bib24","first-page":"149","article-title":"Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery \u2013 focus on the paclitaxel eluting stent","volume":"7","author":"Litsky","year":"2014","journal-title":"Med Devices (Auckl)"},{"key":"10.1016\/j.jvssci.2024.100277_bib25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jvs.2011.01.047","article-title":"First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease","volume":"54","author":"Lammer","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvssci.2024.100277_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1583\/05-1704.1","article-title":"Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial","volume":"13","author":"Duda","year":"2006","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvssci.2024.100277_bib27","series-title":"Handbook of vascular Motion","first-page":"191","article-title":"Chapter 10 - Lower Extremity arteries","author":"Cheng","year":"2019"},{"key":"10.1016\/j.jvssci.2024.100277_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.vph.2015.06.007","article-title":"Healing arterial ulcers: endothelial lining regeneration upon vascular denudation injury","volume":"72","author":"McDonald","year":"2015","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jvssci.2024.100277_bib29","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvssci.2024.100277_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.23736\/S0392-9590.20.04462-4","article-title":"A systematic review and meta-analysis of bioresorbable vascular scaffolds for below-the-knee arterial disease","volume":"40","author":"Ipema","year":"2021","journal-title":"Int Angiol"},{"key":"10.1016\/j.jvssci.2024.100277_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1526602815620618","article-title":"Evaluation of the biodegradable Igaki-Tamai scaffold after drug-eluting balloon treatment of de novo superficial femoral artery lesions: the GAIA-DEB study","volume":"23","author":"Werner","year":"2016","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvssci.2024.100277_bib32","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41598-022-26654-5","article-title":"Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta-analysis","volume":"13","author":"Yin","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jvssci.2024.100277_bib33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.110.971606","article-title":"Bioresorbable scaffold","volume":"123","author":"Onuma","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jvssci.2024.100277_bib34","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1021\/acs.biomac.9b00159","article-title":"Biocompatibility of resorbable polymers: a historical perspective and framework for the future","volume":"20","author":"Pappalardo","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jvssci.2024.100277_bib35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1021\/bm0494702","article-title":"Aliphatic polyesters: great degradable polymers that cannot do everything","volume":"6","author":"Vert","year":"2005","journal-title":"Biomacromolecules"},{"year":"2012","series-title":"Poly(Lactic acid)-based biomaterials: Synthesis, modification and applications. In: Biomedical science, Engineering and technology [Internet]. IntechOpen","author":"Xiao","key":"10.1016\/j.jvssci.2024.100277_bib36"},{"key":"10.1016\/j.jvssci.2024.100277_bib37","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jvs.2016.05.066","article-title":"Treatment of the femoropopliteal artery with the bioresorbable REMEDY stent","volume":"64","author":"Bontinck","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvssci.2024.100277_bib38","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.jcin.2016.06.005","article-title":"Experience with the absorb everolimus-eluting bioresorbable vascular scaffold in arteries below the knee: 12-month clinical and imaging outcomes","volume":"9","author":"Varcoe","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvssci.2024.100277_bib39","article-title":"Evaluation of an infrapopliteal drug-eluting resorbable scaffold: design methodology for the LIFE-BTK randomized controlled trial","volume":"2","author":"Varcoe","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.jvssci.2024.100277_bib40","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.jacc.2014.09.041","article-title":"Current status of bioresorbable scaffolds in the treatment of coronary artery disease","volume":"64","author":"Wiebe","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvssci.2024.100277_bib41","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00270-008-9472-8","article-title":"Ams INSIGHT\u2014absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis","volume":"32","author":"Bosiers","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvssci.2024.100277_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2305637","article-title":"Drug-eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease","volume":"390","author":"Varcoe","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvssci.2024.100277_bib43","article-title":"Long-term efficacy and safety of everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomized trials","volume":"10","author":"Mahmoud","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvssci.2024.100277_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/1526602817698935","article-title":"Lessons learned regarding handling and deployment of the absorb bioresorbable vascular scaffold in infrapopliteal arteries","volume":"24","author":"Varcoe","year":"2017","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvssci.2024.100277_bib45","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jcin.2016.02.051","article-title":"Bioresorbable everolimus-eluting vascular scaffold for patients with peripheral artery disease (ESPRIT I): 2-year clinical and Imaging results","volume":"9","author":"Lammer","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvssci.2024.100277_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jcin.2019.10.059","article-title":"The IN.PACT DEEP clinical drug-coated balloon trial: 5-year outcomes","volume":"13","author":"Zeller","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvssci.2024.100277_bib47","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.jacc.2023.09.830","article-title":"Disparities in diagnosis, treatment, and outcomes of peripheral artery disease: JACC scientific statement","volume":"82","author":"McDermott","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvssci.2024.100277_bib48","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00270-012-0524-8","article-title":"Current status of interventional radiology treatment of infrapopliteal arterial disease","volume":"36","author":"Rand","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvssci.2024.100277_bib49","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jvssci.2024.100277_bib50","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3390\/polym14061099","article-title":"3D printing of polymeric bioresorbable stents: a strategy to improve both cellular compatibility and mechanical properties","volume":"14","author":"Sousa","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.jvssci.2024.100277_bib51","doi-asserted-by":"crossref","first-page":"45422","DOI":"10.1021\/acsami.4c07364","article-title":"Polydiolcitrate\u2013MoS2 composite for 3D printing radio-opaque, bioresorbable vascular scaffolds","volume":"16","author":"Szydlowska","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jvssci.2024.100277_bib52","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.3390\/molecules25204624","article-title":"Drug-eluting stents and balloons\u2014materials, structure designs, and coating techniques: a review","volume":"25","author":"Rykowska","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jvssci.2024.100277_bib53","article-title":"One year outcomes of Zilver PTX versus eluvia for femoropopliteal disease in real-world practice: REALDES study","author":"Shibata","year":"2023","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvssci.2024.100277_bib54","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(18)32262-1","article-title":"A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial","volume":"392","author":"Gray","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jvssci.2024.100277_bib55","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","article-title":"1-Year results from the RANGER II SFA randomized trial of the ranger drug-coated balloon","volume":"14","author":"Sachar","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvssci.2024.100277_bib56","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jcin.2018.10.001","article-title":"The era of drug-coated balloons","volume":"11","author":"Klein","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"12_Supplement","key":"10.1016\/j.jvssci.2024.100277_bib57","doi-asserted-by":"crossref","first-page":"B55","DOI":"10.1016\/j.jacc.2022.08.154","article-title":"TCT-132 in vitro benchtop assessment of particulate generation from drug-coated balloons","volume":"80","author":"Koh","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvssci.2024.100277_bib58","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jvir.2018.02.006","article-title":"Biologic drug effect and particulate embolization of drug-eluting stents versus drug-coated balloons in healthy swine femoropopliteal arteries","volume":"29","author":"Torii","year":"2018","journal-title":"J Vasc Intervent Radiol"},{"key":"10.1016\/j.jvssci.2024.100277_bib59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/15266028221120755","article-title":"Liquid drug delivery Approaches for the treatment of occlusive arterial disease: a systematic review","volume":"31","author":"Todd","year":"2024","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvssci.2024.100277_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1184816","article-title":"Pre-clinical investigation of liquid sirolimus for local drug delivery","volume":"10","author":"Todd","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jvssci.2024.100277_bib61","first-page":"393","article-title":"A universal drug delivery catheter for the treatment of infrapopliteal arterial disease using liquid therapy","volume":"96","author":"Bunch","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvssci.2024.100277_bib62","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jcin.2017.12.015","article-title":"Adventitial drug delivery of dexamethasone to improve primary patency in the treatment of superficial femoral and popliteal artery disease: 12-month results from the DANCE clinical trial","volume":"11","author":"Razavi","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvssci.2024.100277_bib63","article-title":"Intravascular brachytherapy for peripheral vascular disease","volume":"2014","author":"Andras","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvssci.2024.100277_bib64","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.brachy.2022.05.004","article-title":"Coronary intravascular brachytherapy for in-stent restenosis: a review of the contemporary literature","volume":"21","author":"Detloff","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.jvssci.2024.100277_bib65","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1051-0443(07)61569-3","article-title":"Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial","volume":"12","author":"Waksman","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvssci.2024.100277_bib66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jvssci.2021.04.001","article-title":"Targeting smooth muscle cell phenotypic switching in vascular disease","volume":"2","author":"Chakraborty","year":"2021","journal-title":"JVS Vasc Sci"},{"key":"10.1016\/j.jvssci.2024.100277_bib67","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty","volume":"330","year":"1994","journal-title":"N Engl J Med"},{"issue":"6 Supplement","key":"10.1016\/j.jvssci.2024.100277_bib68","doi-asserted-by":"crossref","first-page":"A33","DOI":"10.1016\/j.jvs.2007.02.069","article-title":"Integrin \u03b1v\u03b23 as a target in the prevention of neointimal hyperplasia","volume":"45","author":"Kokubo","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvssci.2024.100277_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128044","article-title":"Fucoidan\/collagen composite coating on magnesium alloy for better corrosion resistance and pro-endothelialization potential","volume":"255","author":"Wang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jvssci.2024.100277_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/jbm.b.35350","article-title":"Biodegradable AZ91 magnesium alloy\/sirolimus\/poly D, L-lactic-co-glycolic acid-based substrate for cardiovascular device application","volume":"112","author":"Mohanta","year":"2024","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.jvssci.2024.100277_bib71","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jbm.b.33224","article-title":"The (PrS\/HGF-pDNA) multilayer films for gene-eluting stent coating: gene-protecting, anticoagulation, antibacterial properties, and in vivo antirestenosis evaluation","volume":"103","author":"Chang","year":"2015","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.jvssci.2024.100277_bib72","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41551-023-01022-4","article-title":"A battery-less wireless implant for the continuous monitoring of vascular pressure, flow rate and temperature","volume":"7","author":"Kwon","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jvssci.2024.100277_bib73","article-title":"Detection of blood clots using a whole stent as an active implantable biosensor","volume":"11","author":"Kirimi","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.jvssci.2024.100277_bib74","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2337\/cd20-0043","article-title":"Using continuous glucose monitoring in clinical practice","volume":"38","author":"Miller","year":"2020","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.jvssci.2024.100277_bib75","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006863","article-title":"Lower rates of heart failure and all-cause hospitalizations during pulmonary artery pressure-guided therapy for ambulatory heart failure","volume":"13","author":"Shavelle","year":"2020","journal-title":"Circ Heart Fail"}],"container-title":["JVS-Vascular Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666350324000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666350324000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:16:41Z","timestamp":1765819001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666350324000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":75,"alternative-id":["S2666350324000889"],"URL":"https:\/\/doi.org\/10.1016\/j.jvssci.2024.100277","relation":{},"ISSN":["2666-3503"],"issn-type":[{"type":"print","value":"2666-3503"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moving away from metal: Step toward the future with bioresorbable vascular scaffolds and novel antiproliferative agents","name":"articletitle","label":"Article Title"},{"value":"JVS-Vascular Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvssci.2024.100277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}],"article-number":"100277"}}